Keyword: prostate

Brevity: Headers | « Text »
  • Why Do People Hate Feminism #10 - #Feminism is a Supremacy Movement

    09/08/2016 8:26:43 AM PDT · by No_More_Harkin · 6 replies
    YouTube ^ | 9/6/2016 | Sargon of Akkad
    link only
  • Sanders' Proposal Sets a Dangerous Precedent

    04/07/2016 7:00:57 AM PDT · by Kaslin · 75 replies ^ | April 7, 2016 | Ken Blackwell
    Last week, presidential candidate Senator Bernie Sanders joined 11 other members of Congress in sending a letter to the National Institute of Health (NIH), urging the agency to cut costs for the prostate cancer drug, Xtandi, by employing its “march-in rights.” These rights, which have never before been utilized by the NIH, were established in 1980 under the Bayh-Dole Act, which gives federal agencies the authority to license a patent when action is deemed necessary, primarily as an emergency tactic. Using this provision as their justification, lawmakers are requesting that NIH override Xtandi’s patent protection, which guarantees its manufacturers exclusive...
  • Wash. Post: "Greenspan is in the hospital for an enlarged PROSTITUTE"

    04/24/2003 4:34:20 AM PDT · by A Vast RightWing Conspirator · 36 replies · 193+ views
    Wash Post as Read on C-Span | Apr. 24, 2003
    It's in the Wash. Post folks. I SAW the article and that was the exact wording, as the C-Span guy was reading the paragraph. LOL
  • Having sex with 21 women saves you from prostate cancer

    10/28/2014 12:58:36 PM PDT · by BenLurkin · 168 replies ^ | 28 October 2014 | Daniel Tomas on
    Having an impressive love-making record may protect you against prostate cancer, as new evidence from Canadian scientists suggests. According to new research published by the University of Montreal, men having sex with more than 20 women, have a 29% lower chance of developing prostate cancer, as opposed to men who have gone through 20 similar sexual experiences with other men.
  • Vasectomy linked with aggressive prostate cancer risk

    07/11/2014 10:59:41 AM PDT · by KeyLargo · 31 replies
    Medical News Today ^ | 10 Jul 2014
    Vasectomy linked with aggressive prostate cancer risk Thursday 10 July 2014 - 3am PST Prostate / Prostate Cancer Men's Health Cancer / Oncology In the largest and most comprehensive study of its kind, researchers from Harvard School of Public Health in Boston, MA, find that vasectomy is associated with a small increased risk of prostate cancer, and a larger increased risk for advanced or lethal prostate cancer. Prostate cancer is a major cause of cancer-related deaths in men in the US, where vasectomy is a common form of contraception, with around 15% of American men having the minor procedure, which...
  • Vasectomy can increase risk of developing lethal prostate cancer

    07/11/2014 10:17:40 AM PDT · by KeyLargo · 11 replies
    The Telegraph ^ | 10 Jul 2014 | Laura Donnelly, and Claire Carter
    Vasectomy can increase risk of developing lethal prostate cancer Scientists have identified a link between having a vasectomy and developing lethal forms of prostate cancer Laura Donnelly, and Claire Carter 10:00PM BST 10 Jul 2014 Men who have a vasectomy face an increased chance of developing prostate cancer and a higher risk of contracting the most aggressive form of the disease, a study has found. The Harvard research on 50,000 men, the largest study to examine the link between sterilisation and cancer, found that those who had the procedure had a 10 per cent greater chance of developing the disease....
  • 'Movember' Is 'Divisive, Gender Normative, Racist'? (it's racist for whites to have moustaches)

    12/02/2013 9:45:28 AM PST · by chessplayer · 63 replies
    Poor Matt Lauer and Al Roker: they spent November growing out beards on NBC for “Movember,” to promote men's health, but the British magazine New Statesman has announced “Movember is divisive, gender normative, racist and ineffective against some very real health issues.” RedState’s Erick Erickson tweeted “You cannot parody the left. You just can't. You may think it is parody, but damned if they don't one up you.” Apparently moustaches are for minorities: So what message does Movember convey to those whose moustaches are more-or-less permanent features? With large numbers of minority-ethnic men—for instance Kurds, Indians, Mexicans—sporting moustaches as a...
  • College Newspaper Editor Deems ‘Movember’ Activism ‘Sexist, Racist, Transphobic’

    11/30/2013 8:43:13 AM PST · by KeyLargo · 36 replies ^ | November 29, 2013 | Andrew Kirell
    College Newspaper Editor Deems ‘Movember’ Activism ‘Sexist, Racist, Transphobic’ by Andrew Kirell | 11:39 am, November 29th, 2013 If you’re a man who grows a November mustache for “Movember” charities benefiting prostate cancer research, you might be engaging in a “sexist, racist, transphobic, and misinformed” campaign, says the editor of McGill University’s student newspaper. Health and Education Editor Ralph Haddad penned an op-ed “Movember as microaggression” in a recent issue of the school’s paper. As HyperVocal points out, McGill is Canada’s equivalent of Harvard, and so the content within is full of the sort of academic pretenses one might expect....
  • Fish oil, Omega-3 causes huge increase in risk of prostate cancer

    07/16/2013 6:41:52 PM PDT · by chessplayer · 96 replies
    (AFP) – US scientists said Wednesday they have confirmed a surprising 2011 study that found a higher risk of prostate cancer among men who consume omega-3 fatty acids, raising new questions about the safety of supplements. The research in the Journal of the National Cancer Institute reported a 71 percent higher risk for dangerous high-grade prostate cancer among men who ate fatty fish or took fish-oil supplements, which are often touted for their anti-inflammatory properties. A large European study also found the same omega-3 and prostate cancer link.
  • Nutri. Conventional Wisdom Takes It on Chin: Salt Harmless, Fish Oil Hikes Risk of Prostate Cancer

    07/11/2013 1:31:27 PM PDT · by servo1969 · 22 replies ^ | 7-11-2013 | Rush Limbaugh
    BEGIN TRANSCRIPT RUSH: Here it is. The Centers for Disease Control and Prevention in Atlanta admit a long-standing error. "There is no benefit in reducing salt." Again, from the Centers for Disease Control: "There is no benefit in reducing salt." They are correcting a long-standing error. These are the kind of stories I just eat up. I just lick these stories like a salt lick. I love these stories. I just love it when conventional wisdom is turned upside down, when the food Nazis are exposed as the deceitful frauds that they are. "A recent report commissioned by the Centers...
  • Obama's Looming Prostate Cancer Death Epidemic,; Technocrat Doctors Turn Against Patients

    11/28/2012 3:40:44 PM PST · by morphing libertarian · 77 replies
    Sun Beam Times ^ | November 28, 2012 | Dr. David McKalip
    Prostate can deaths projected to increase. Restrictions on care and older population forming a perfect storm.
  • Prostate cancer drug so effective trial stopped

    06/03/2012 12:12:44 AM PDT · by LibWhacker · 25 replies
    sfgate ^ | 6/2/12 | Victoria Colliver
    A new drug for advanced prostate cancer patients has proved so effective that researchers stopped the clinical trial early to give all patients a chance to receive the life-extending medication, according to a UCSF-led study released Saturday. The hormone treatment, Johnson & Johnson's Zytiga, when added to a standard steroid therapy doubled the time it takes for the disease to progress in patients treated with the standard therapy alone, said the lead researcher, Dr. Charles Ryan, associate professor of clinical medicine at the UCSF Helen Diller Family Comprehensive Cancer Center.
  • New treatment for prostate cancer gives 'perfect results' for nine in ten men: research

    04/16/2012 4:49:05 PM PDT · by Free ThinkerNY · 23 replies
    The Telegraph ^ | April 16, 2012 | Rebecca Smith
    A new treatment for prostate cancer can rid the disease from nine in ten men without debilitating side effects, a study has found, leading to new hope for tens of thousands of men. It is hoped the new treatment, which involves heating only the tumours with a highly focused ultrasound, will mean men can be treated without an overnight stay in hospital and avoiding the distressing side effects associated with current therapies. A study has found that focal HIFU, high-intensity focused ultrasound, provides the 'perfect' outcome of no major side effects and free of cancer 12 months after treatment, in...
  • NICE: Prostate cancer drug too costly for NHS

    02/01/2012 5:00:49 PM PST · by originalbuckeye · 15 replies
    BBCNews ^ | Smitha Mundasad
    A drug that can extend the life of men with advanced prostate cancer by more than three months has provisionally been rejected for NHS use. The health watchdog for England and Wales says the drug's benefits are not enough to justify the price the NHS has been asked to pay. Cancer charities have been angered by the decision about abiraterone, one of the few drugs available to men in the final stages of prostate cancer. A final decision is yet to be made. Prostate cancer is the most common cancer to affect men in the UK. Abiraterone costs just under...
  • Draft Guidelines Recommend Against PSA Screening: USPSTF Review

    10/25/2011 10:38:07 AM PDT · by dangerdoc · 11 replies
    Medscape ^ | 10/13/11 | Zosia Chustecka
    Clinical Context Few topics in the field of preventive medicine are contentious as prostate cancer screening. Widespread screening for prostate cancer has had a remarkable effect on the epidemiology of this tumor, as demonstrated in a study by Welch and Albertsen published in the October 7, 2009, issue of the Journal of the National Cancer Institute. Their study found that the introduction of routine prostate cancer screening led to approximately 1.3 million more men being diagnosed with prostate cancer in the United States alone. Men younger than 60 years accounted for most of this surge in cases. The authors estimated...
  • Panel’s Advice on Prostate Test Sets Up Battle (Obama's death panels alert)

    10/08/2011 7:47:29 AM PDT · by jimbo123 · 67 replies
    NY Times ^ | 10/8/11 | GARDINER HARRIS
    A day after a government panel said that healthy men should no longer get screened for prostate cancer, some doctors’ groups and cancer patients’ advocates began a campaign to convince the nation that the advice was misguided. Their hope is to copy the success of women’s groups that successfully persuaded much of the country two years ago that it was a mistake for the same panel, the United States Preventive Services Task Force, to recommend against routine mammograms for women in their 40s.
  • Medical group to say men don't need prostate cancer screenings, source says

    10/07/2011 8:49:36 AM PDT · by ConorMacNessa · 44 replies ^ | 7 Oct 2011 | Elizabeth Cohen
    The U.S. Preventive Services Task Force, the group that told women in their 40s that they don't need mammograms, will soon recommend that men not get screened for prostate cancer, according to a source privy to the task force deliberations. The task force is set to recommend a "D" rating for prostate specific antigen, or PSA, testing. Such a rating means "there is moderate or high certainty that the service has no net benefit or that the harms outweigh the benefits," according to the group's website. The task force is set to propose this recommendation Tuesday, and then allow for...
  • Former Congressman Mark Foley has prostate cancer, surgery planned for Friday

    07/07/2011 5:51:05 PM PDT · by ConservativeStatement · 8 replies
    South Florida Sun-Sentinel ^ | July 7, 2011 | Anthony Man
    Former Congressman Mark Foley, diagnosed several weeks ago with an aggressive prostate cancer, will have surgery Friday morning to have his prostate removed. Foley, who was a Republican congressman from Palm Beach County for almost 12 years, said in a telephone interview that a battery of tests shows the cancer hasn’t spread beyond the prostate. But after consulting with medical experts and others who’ve had prostate cancer, he’s decided to have his prostate completely removed. He said the prognosis is for a speedy recovery, and he said he could be back at work as early as a week after the...
  • Mushroom compound suppresses prostate tumours

    05/23/2011 7:01:53 AM PDT · by decimon · 16 replies
    Queensland University of Technology ^ | May 23, 2011 | Unknown
    A mushroom used in Asia for its medicinal benefits has been found to be 100 per cent effective in suppressing prostate tumour development in mice during early trials, new Queensland University of Technology (QUT) research shows. The compound, polysaccharopeptide (PSP), which is extracted from the 'turkey tail' mushroom, was found to target prostate cancer stem cells and suppress tumour formation in mice, an article written by senior research fellow Dr Patrick Ling in the international scientific journal PLoS ONE said. Dr Ling, from the Australian Prostate Cancer Research Centre-Queensland and Institute for Biomedical Health & Innovation (IHBI) at QUT, said...
  • Swilling coffee may protect men against prostate cancer (ONLY 6 CUPS A DAY - HEY - PAY ATTENTION!)

    05/18/2011 12:23:38 PM PDT · by Libloather · 23 replies
    MSNBC ^ | 5/17/11 | Robert Bazell
    Swilling coffee may protect men against prostate cancerGuys who drank six cups a day had least risk, says study that debunks long-ago findings By Robert Bazell updated 5/17/2011 7:21:22 PM ET Coffee is good for men, according to research released Tuesday from the Harvard School of Public Health. Those who who drank the most coffee — regular or decaffeinated — have the least risk for prostate cancer, especially the deadliest forms of the disease, the 12-year study of almost 48,000 male health professionals found. But, wait! Almost exactly 30 years ago this same lab in a separate study concluded that...
  • Study suggests another look at testosterone-prostate cancer link

    04/19/2011 10:03:56 AM PDT · by decimon · 3 replies
    Beth Israel Deaconess Medical Center ^ | April 19, 2011 | Unknown
    BOSTON – The long-standing prohibition against testosterone therapy in men with untreated or low-risk prostate cancer merits reevaluation, according to a new study published in The Journal of Urology. "For many decades it had been believed that a history of prostate cancer, even if treated and cured, was an absolute contraindication to testosterone therapy, due to the belief that testosterone activated prostate cancer growth, and could potentially cause dormant cancer cells to grow rapidly," says Abraham Morgentaler, MD of Men's Health Boston. "Generations of medical students and residents were taught that providing testosterone to a man with prostate cancer was...
  • Caution: Centralization Is Dangerous To Your Health

    04/08/2011 6:22:12 AM PDT · by Kaslin · 1 replies ^ | April 9, 2011 | Grace-Marie Turner
    The agency that runs the Medicare program decided in late March that it will pay for patients to receive an advanced new treatment for prostate cancer called Provenge. The decision was cheered by patient groups. The pressure was intense as they demanded that the Centers for Medicare and Medicaid Services (CMS) pay for the pioneering vaccine that already had been approved by the Food and Drug Administration. Early signals indicated the agency might deny payment because the drug is expensive. But Provenge is expensive because it is expensive to make. The drug is created individually using each patient’s own cells...
  • FDA Delay of One Drug Causes 82,000 Lost Life-Years

    10/28/2010 6:23:46 PM PDT · by facedodge · 8 replies ^ | Nov 2010 | William Faloon
    In 2004, I wrote an article describing how Americans die needlessly because of the FDA’s delay in approving lifesaving drugs.1 One example of a delayed therapy I cited was Provenge®, which in the year 2002 had demonstrated improved survival in prostate cancer patients.2 In 2007, Dr. Stephen Strum and I co-authored an article showing how enormous numbers of lives could be spared if scientists were liberated from oppressive FDA over-regulation. We described several cancer drugs that should have been approved including Provenge®, which by the year 2007 had extended survival in several clinical studies.3 In 2010, the FDA finally approved...
  • Cholesterol-lowering drug shrinks enlarged prostates in hamster model

    10/21/2010 3:29:22 PM PDT · by decimon · 15 replies
    Children's Hospital Boston ^ | October 21, 2010 | Unknown
    Boston, Mass. - A cholesterol-lowering drug reduced the enlarged prostates of hamsters to the same extent as a drug commonly used to treat benign prostatic hyperplasia (BPH), report researchers at Children's Hospital Boston and their colleagues in the October issue of the Journal of Urology. Together, the drugs worked even better. "We don't know the mechanism, but the results suggest to us that lowering cholesterol has the potential to reduce BPH in men," says senior author Keith Solomon, PhD, a biochemist, and member of the departments of Orthopaedic Surgery and Urology at Children's. "This brings up the possibility that other...
  • "Pink" is for breast cancer awareness, but what's out there for prostate cancer awareness?

    10/11/2010 1:40:31 PM PDT · by brycemax · 41 replies
    Here's a cartoon to remind you that this is "Breast Cancer Awareness Month". Do what you can to save the ta-tas! That being said, do you know when "Prostate Cancer Awareness Month" is? Probably not. What's needed is a symbol men can relate to which will drive THAT message home.
  • Antibody finds, wipes out prostate cancer: study

    12/28/2009 5:35:49 PM PST · by LibWhacker · 22 replies · 997+ views
    PhysOrg | AFP ^ | 12/28/09
    US researchers have found an antibody that hunts down prostate cancer cells in mice and can destroy the killer disease even in an advanced stage, a study showed Monday.The antibody, called F77, was found to bond more readily with cancerous prostate tissues and cells than with benign tissue and cells, and to promote the death of cancerous tissue, said the study published in the Proceedings of the National Academy of Science (PNAS). When injected in mice, F77 bonded with tissue where prostate cancer was the primary cancer in almost all cases (97 percent) and in tissue cores where the cancer...
  • Harvard School of Public Health: Coffee, Exercise Can Help Men Defeat Prostate Cancer

    12/08/2009 8:04:27 PM PST · by SeekAndFind · 15 replies · 1,093+ views
    Boston (SmartAboutHealth) - According to two new studies, coffee and exercise may be the keys to men beating prostate cancer. The first study was carried out by researchers from the Harvard School of Public Health, and was led by Kathryn M. Wilson. The study focused on data from 50,000 men to get an idea as to the rate at which prostate cancer was being diagnosed, and whether or not coffee would help in any way. Over a 20-year period from 1986 to 2006, there were nearly 5,000 cases of prostate cancer diagnosed out of the 50,000 men. What they found...

    11/27/2009 5:59:51 PM PST · by nutsonthebus · 10 replies · 796+ views
    Less than 24 hours ago, I lay prostrate on an operating table while surgeons aided by a robot(da Vinci) made six deep cuts in my belly area and carved out my oversized cancerous prostate. The robot allegedly made such precise cuts that important nerves and muscles were protected from damage so my functionality would be maintained. Makes one wonder if you can rent it for carving turkey— Hmmmm.
  • Prostatectomy: Almost as painful as watching the Obama presidency

    11/25/2009 9:13:09 PM PST · by darrellmaurina · 12 replies · 1,008+ views
    Pulaski County Daily News ^ | 11/25/2009 | Dave Weinbaum
    Less than 24 hours ago, I lay prostrate on an operating table while surgeons aided by a robot (da Vinci) made six deep cuts in my belly area and carved out my oversized cancerous prostate. The robot allegedly made such precise cuts that important nerves and muscles were protected from damage so my functionality would be maintained. Makes one wonder if you can rent it for carving turkey — Hmmmm.
  • Manager: Dennis Hopper has prostate cancer

    10/29/2009 7:30:07 PM PDT · by NormsRevenge · 27 replies · 1,342+ views
    AP on Yahoo ^ | 10/29/09 | AP
    LOS ANGELES – Dennis Hopper has been diagnosed with prostate cancer and is canceling all travel plans to focus on treatment. Manager Sam Maydew says the 73-year-old actor and artist is being treated through a "special program" at the University of Southern California. Asked about Hopper's prognosis, Maydew said, "We're hoping for the best."
  • NJ women pose nude for prostate cancer calendar

    10/27/2009 8:38:39 AM PDT · by ConservativeStatement · 58 replies · 3,790+ views
    AP ^ | October 27, 2009
    WYCKOFF, N.J. — Twelve Jersey girls have shed their clothes to pose for a calendar to raise awareness about prostate cancer. Proceeds from “Stand By Your Man: 12 Women in Support of a Cure for Prostate Cancer” will go to the Prostate Cancer Coalition of New Jersey.
  • Gadget can diagnose prostate cancer in 30 minutes

    09/27/2009 3:32:59 PM PDT · by Nachum · 19 replies · 1,285+ views
    The ^ | 9/27/09 | Joseph Hall, Megan Ogilvie
    Toronto researchers have developed a portable device they say will accurately diagnose prostate cancer in 30 minutes. The microchip technology, created by a pair of University of Toronto scientists, will be able to determine the severity of the tumours through a simple urine sample and produce quick diagnosis with no need for painful biopsies.
  • Dodd Diagnosed with Prostate Cancer

    08/03/2009 10:42:15 AM PDT · by guido911 · 28 replies · 989+ views
    Per MSNBC
  • Dodd Has Prostate Cancer

    07/31/2009 10:00:49 AM PDT · by madison10 · 63 replies · 2,107+ views ^ | July 31, 2009 | Laura Kellman
    WASHINGTON – Sen. Christopher Dodd, D-Conn., has been diagnosed with an early stage of prostate cancer and intends to have surgery early in August, his office said Friday. Dodd intends to be back at work when Congress reconvenes in September, according to an e-mail his office circulated to fellow senators. The AP obtained a copy. Aides also said the diagnosis would not affect Dodd's plans to seek a sixth term in 2010.
  • Mayo reports dramatic outcomes in prostate cancer study

    06/19/2009 5:01:05 PM PDT · by Daffynition · 26 replies · 1,495+ views ^ | Jun 19 2009 1 | Susan Perry
    Two prostate cancer patients who had been told their condition was inoperable are now cancer-free as the result of an experimental therapy, the Mayo Clinic in Rochester announced today. “We were all pretty shocked,” says Dr. Eugene Kwon, an immunologist and urologist at Mayo and leader of the clinical trial in which the experimental therapy was being used. “These results were far beyond anything we ever envisioned.” The two patients had a particular subset of prostate cancer that is very aggressive and deadly. Unlike most prostate cancer, which grows slowly and usually remains confined to the prostate gland, aggressive forms...
  • Experimental Drug Saves Two Men With Inoperable Prostate Cancer

    06/21/2009 9:52:00 PM PDT · by Steelfish · 6 replies · 534+ views
    Daily Mirror (UK) ^ | June 21, 2009
    Experimental drug saves two men with inoperable prostate cancer By FIONA MACRAE 21st June 2009 Two men with inoperable prostate cancer have made dramatic recoveries after being given a single dose of an experimental drug. Both men are now cancer-free and their doctors say their progress has exceeded all their expectations. Dr Eugene Kwon, of the respected Mayo Clinic in Minnesota, said: 'This is one of the Holy Grails of prostate cancer research. We have been looking for this for many years.' Prostate cancer is the most common cancer in British men, with nearly 35,000 cases a year, 10,000 deaths...
  • A Urine Test for Prostate Cancer?

    02/17/2009 10:39:44 PM PST · by neverdem · 3 replies · 532+ views
    ScienceNOW Daily News ^ | 11 February 2009 | Jennifer Couzin
    Oncologists who treat prostate cancer have long been frustrated by a quagmire: They know they treat many men whose disease won't harm them, but at the same time they fail to catch aggressive cases that kill. There's no good way to separate the two right now, but in tomorrow's issue of Nature, a team at the University of Michigan, Ann Arbor, suggests a new strategy: Look for specific chemicals in urine that could distinguish among patients with no sign of disease, disease that isn't critical to treat, and disease that's most dangerous. Researchers have poured tremendous energy into early cancer...
  • Researchers Discover How To Halt Prostate Cancer Spread

    11/25/2008 8:35:18 AM PST · by Main Street · 20 replies · 9,265+ views
    emaxhealth ^ | 11/25/2008 | emaxhealth
    There is a new breakthrough in search for prostate cancer treatment. Following three years of study, University of Southern California researchers have found a way to halt the spread of prostate cancer. Suppression of the GRP78 protein, a genetic biomarker of aggressive prostate cancer, leads researchers to what they consider a "breakthrough" in cancer research. Amy Lee, professor of biochemistry and molecular biology at the Keck School of Medicine of USC, the study's principal investigator, says, "This research has far-reaching implications in a wide range for human cancers," GRP78 contributes to the spread of prostate cancer. It protects tumors, and...
  • New Study Strengthens Association Of Prostate Cancer With Exposure To Agent Orange

    05/16/2008 8:49:39 AM PDT · by blam · 5 replies · 662+ views
    Science Daily ^ | 5-16-2008 | American Urological Association
    New Study Strengthens Association Of Prostate Cancer With Exposure To Agent Orange ScienceDaily (May 16, 2008) — As men age, their risk of developing prostate cancer increases. Aging Vietnam veterans are giving researchers new opportunities to solidify the connection between in-country exposure to Agent Orange and subsequent prostate cancer development. In a study presented during the Annual Scientific Meeting of the American Urological Association (AUA) in Orlando, researchers presented data from a large study of veterans enrolled in the Northern California VA System, examining prostate cancer incidence and disease characteristics in those exposed to Agent Orange compared to those who...
  • Prostate Cancer Can Be Halted With Anti-inflammatory And Statin Used In Tandem, Study Suggests

    04/14/2008 5:01:48 PM PDT · by blam · 27 replies · 322+ views
    Science Daily ^ | 4-14-2008 | Rutgers University
    Prostate Cancer Can Be Halted With Anti-inflammatory And Statin Used In Tandem, Study Suggests ScienceDaily (Apr. 14, 2008) — Researchers at Rutgers' Ernest Mario School of Pharmacy have shown that administering a combination of the widely used drugs Celebrex (celecoxib, a nonsteroidal anti-inflammatory drug) and Lipitor (atorvastatin, a cholesterol lowering drug) stops the transition of early prostate cancer to its more aggressive and potentially fatal stage. Prostate cancer is the second leading cause of cancer death in men in the United States, with more than a quarter-million new cases appearing each year, according to the American Cancer Society. The findings...
  • $300 to Learn Risk of Prostate Cancer

    01/18/2008 7:57:43 AM PST · by shrinkermd · 19 replies · 73+ views
    NY Times ^ | 17 January 2008 | Gina Kolata
    A combination of common and minor variations in five regions of DNA can help predict a man’s risk of getting prostate cancer, researchers reported Wednesday. A company formed by researchers at Wake Forest University School of Medicine is expected to make the test available in a few months, said Karen Richardson, a Wake Forest spokeswoman. It should cost less than $300. This is, some medical experts say, a first taste of what is expected to be a revolution in medical prognostication. The results, they agree, are clear. But the question is what happens next. And will patients be helped or...
  • No Evidence That Widely Prescribed Statins Protect Against Prostate Cancer

    08/09/2007 7:39:00 PM PDT · by blam · 4 replies · 274+ views
    Science Daily ^ | 8-10-2007 | American Association Of Cancer Research
    Source: American Association for Cancer Research Date: August 10, 2007 No Evidence That Widely Prescribed Statins Protect Against Prostate Cancer Science Daily — A large community-based study refutes previous findings that statins -- a top-selling drug class, worldwide -- might cut one's risk of developing prostate cancer by reducing production of the male hormones that fuel cancer growth. Researchers from the New England Research Institutes found that while men using statins did indeed have lower blood levels of androgens such as testosterone, it was more likely attributable to poor health rather than the use of statins. "The public health significance...
  • Red Wine Protects the Prostate

    07/28/2007 5:22:59 AM PDT · by Renfield · 71 replies · 1,647+ views ^ | 5-21-07
    Newswise — Researchers have found that men who drink an average of four to seven glasses of red wine per week are only 52% as likely to be diagnosed with prostate cancer as those who do not drink red wine, reports the June 2007 issue of Harvard Men’s Health Watch. In addition, red wine appears particularly protective against advanced or aggressive cancers. Researchers in Seattle collected information about many factors that might influence the risk of prostate cancer in men between ages 40 and 64, including alcohol consumption. At first the results for alcohol consumption seemed similar to the findings...
  • (Prostate) Cancer therapy delay attacked (FDA, threats)

    07/05/2007 9:34:52 PM PDT · by Tired of Taxes · 30 replies · 1,255+ views
    msnbc ^ | 7-5-07 | Rob Stein
    Oncologists do not usually need bodyguards when they present scientific data at a medical symposium. But when Howard I. Scher of the Memorial Sloan-Kettering Cancer Center and Maha Hussain of the University of Michigan spoke at the recent meeting of the American Society of Clinical Oncology, they were in fear for their safety. The two doctors have been at the center of an unusually bitter debate over an experimental therapy for prostate cancer, ever since they helped persuade the Food and Drug Administration to delay approving it, enraging both patients and investors. The first-of-its-kind therapy, called Provenge, is a "vaccine"...
  • Most Common Cancer Kills 500 Every Week

    06/17/2007 10:40:54 PM PDT · by Coleus · 60 replies · 1,912+ views
    CBN ^ | 06.11.07 | Gailon Totheroh
    The most common category of cancer may not be what you think it is. It's not breast cancer -- that's number three. And lung cancer is number two. With 218,000 new cases expected in 2007, number one is prostate cancer. This cancer is not just striking retired men. "The fact is prostate cancer happens most commonly to men in their 40s, 50s, and 60s. In other words, it occurs while men are at work." Surgeon Arnon Krongrad says those busy men often overlook the importance of getting tested. That means getting what's known as a PSA test. It measures blood...
  • Prostate Cancer Seen As Major Cause of Prostate Cancer Deaths

    05/16/2007 11:50:56 AM PDT · by bedolido · 25 replies · 673+ views ^ | 05-16-2007 | Biff Scuzzy (gotta be a fake name)
    LONDON - A study has determined that men who are diagnosed with prostate cancer are nearly twenty-five times as likely to die from the disease as men who are prostate-cancer free. This conclusion was reached after a team of researchers had carefully recorded the causes of death of more than 300,000 men.
  • Men With No Sons More At Risk For Prostate Cancer, According To New Study

    01/04/2007 3:15:55 PM PST · by blam · 18 replies · 412+ views
    Science News ^ | 1-4-2007 | Columbia University
    Source: Columbia University's Mailman School of Public Health Date: January 4, 2007 Men With No Sons More At Risk For Prostate Cancer, According To New Study Science Daily — In a new and unique study to determine if genes on the Y chromosome are involved in prostate cancer, researchers at Columbia University's Mailman School of Public Health in conjunction with Hebrew University of Jerusalem found that men who had only daughters had a higher risk of prostate cancer than men who had at least one son, thus signifying a possible defect on the father's Y chromosome. The results, published in...
  • New prostate probe does it all in 1 shot

    09/21/2006 8:16:11 AM PDT · by FairWitness · 32 replies · 1,032+ views ^ | 9-21-06 | Mary Jo Feldstein
    A local company has developed a scanning system that allows physicians to more accurately detect and treat prostate cancer, a leading cause of death among men. The new technology, introduced by Envisioneering Medical Technologies of Overland, allows physicians to generate a full 3-D image of the prostate, manipulate the image and take precise biopsies of targeted tissue. With TargetScan 3D, physicians can obtain a better view of the prostate and more-accurate biopsy results in less time than with traditional equipment, said Robert Mills, the president of Envisioneering. Several academic medical centers, including Washington University's School of Medicine and New York...
  • Prostate Cancer Test Declared Useless By PSA Pioneer

    09/10/2006 5:41:18 PM PDT · by Coleus · 3 replies · 660+ views
    Health Talk ^ | 09.11.06
    The PSA test, used to screen men for detecting prostate cancer has been declared all but useless by a pioneer in the procedure. Stanford University School of Medicine professor Dr. Thomas Stamey said "The PSA era is over in the United States." Dr. Stamey and colleagues examined more than 1,300 prostate tissue samples removed by urologists at Stanford over the past 20 years. Researchers divided the data from the samples into four five-year periods between 1983 and 2004. They found a substantial decrease in the connection between PSA levels and the amount of prostate cancer over time. In the first...
  • Risky Legacy: African DNA Linked To Prostate Cancer

    08/27/2006 11:30:50 AM PDT · by blam · 6 replies · 538+ views
    Science News ^ | 8-27-2006 | Ben Harder
    Risky Legacy: African DNA linked to prostate cancer Ben Harder The high rate of prostate cancer among African American men may result in large part from a newly identified stretch of DNA passed down from their African ancestors. A black man's odds of developing prostate cancer by age 55 are more than twice those of a white man. The racial discrepancy is less pronounced when the disease appears later. Researchers have suspected for years that genetic factors account for part of the racial difference in risk. Most African Americans have both African and European forebears, so their chromosomes are mosaics...